Michelle Kinder

Michelle Kinder, Ph.D., is the Senior Director of Translational Sciences at Incyte, a biopharmaceutical company.1 She is based in the Greater Philadelphia area and has over 500 connections on LinkedIn.1

Professional Background

Dr. Kinder has a strong background in scientific research and pharmaceutical development. She earned her Ph.D. from the University of Pennsylvania1, which has likely contributed to her expertise in translational sciences.

Role at Incyte

As the Director of Translational Sciences, Dr. Kinder plays a crucial role in bridging the gap between basic research and clinical applications. Her work likely involves:

• Overseeing the translation of scientific discoveries into potential therapeutic interventions
• Collaborating with various departments to advance drug development programs
• Applying scientific knowledge to improve patient outcomes

Contributions and Initiatives

Dr. Kinder is actively involved in several initiatives at Incyte:

1. Postdoctoral Fellowship Program: She has been involved in recruiting PharmD and PhD graduates for Incyte's postdoctoral fellowship program in partnership with Saint Joseph's University.2

2. Myeloid Cell Research: Dr. Kinder has contributed insights on myeloid cells within the tumor microenvironment, suggesting the need for updated paradigms in this area of research.4

3. Team Leadership: She leads the Translational Sciences department at Incyte, describing her team as "funny, creative, hardworking, friendly, and scientific".3

Dr. Michelle Kinder's role at Incyte combines scientific expertise with leadership skills, contributing to the company's efforts in developing innovative therapies and advancing translational research in the biopharmaceutical industry.